Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WHEATON® to Launch New Website Supporting Clinical and Life Science Customers

Published: Monday, November 19, 2012
Last Updated: Monday, November 19, 2012
Bookmark and Share
Consolidating its brand in the UK, WHEATON is providing local support and access to a full line of liquid handling and packaging products whilst maintaining stocking supply for the NHS.

Laboratory Sales Limited (LSL) has become WHEATON, offering researchers and clinicians a single brand name for pharmaceutical, diagnostic, biotechnology and cosmetic packaging products.

Supporting the consolidation, WHEATON has launched www.wheaton-uk.com, a new website that offers access to the products and manufacturing services formerly available from LSL.

Here, customers will find one of the U.K.’s premier suppliers of high quality glass and plastic consumables including tubular and moulded glass vials, dropper pipettes, test tubes, sample containers, ampoules and packaging products.

As an inventory stock supplier to the National Health Service (NHS) in the UK, WHEATON features its extensive clinical products portfolio on the website and is offering a new Clinical Products Guide brochure.

WHEATON is dedicated to providing today’s most innovative solutions for the laboratory research, diagnostic packaging and specialty pharmaceuticals industries.

The new WHEATON website provides our UK customers a sleek user interface, supports faster navigation, and is designed for improved product searchability.

Like its American counterpart, the UK site sets a new standard for user friendliness and interactivity. Links are provided to Twitter and Facebook for sharing and commenting on site content and posts are regularly updated.

The new UK website leverages the strength and recognition of the global WHEATON name whilst maintaining and enhancing manufacturing capabilities and product portfolios.

After the launch of the new website in mid-November, it is expected that the changeover will be complete by 1st January 2013.

“We acquired Laboratory Sales Limited (LSL) nearly two years ago and wanted to make it easier for scientists to find our products and get the support they need,” says Wayne Brinster, president of WHEATON.

“Going forward as WHEATON makes it easier to do business with us, giving scientists more time to pursue their investigations…and we know that the science comes first,” he added.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Wayne Brinster Joins WHEATON® as President
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.
Friday, October 26, 2012
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!